David Einhorn’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

David Einhorn’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$6.61M	Buy	162,578 +6,200	+4%	+$228K	0.32%	28
2023 Q3	$5.4M	Buy	156,378 +6,210	+4%	+$242K	0.31%	24
2023 Q2	$6.11M	Sell	150,168 -1,200	-0.8%	-$48.9K	0.29%	25
2023 Q1	$5.85M	Sell	151,368 -3,990	-3%	-$164K	0.32%	26
2022 Q4	$6.89M	Buy	155,358 +8,970	+6%	+$377K	0.48%	22
2022 Q3	$6.24M	Hold	146,388	–	–	0.44%	23
2022 Q2	$8.17M	Sell	146,388 -13,812	-9%	-$819K	0.64%	24
2022 Q1	$9.9M	Sell	160,200 -24,800	-13%	-$1.52M	0.63%	28
2021 Q4	$10.2M	Buy	+185,000	New	+$9.7M	0.58%	26

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

David Einhorn's LKFT Position: Q4 2023 in Review

David Einhorn increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 4% in Q4 2023, buying an estimated $228K and bringing the position to 162,578 shares worth $6.61M. The position accounts for 0.32% of the portfolio, ranked #28.

David Einhorn first reported a position in LKFT in Q4 2021 and has held it in 9 quarters since. The position peaked at $10.2M in Q4 2021. 88 funds tracked by Wall St. Rank hold LKFT as of Q4 2023.

David Einhorn held 162,578 shares of Lakefront Biotherapeutics American Depositary Shares worth $6.61M as of Q4 2023.
David Einhorn bought 6,200 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2023, an estimated $228K.
Lakefront Biotherapeutics American Depositary Shares made up 0.32% of David Einhorn's portfolio in Q4 2023, its #28 holding.
David Einhorn first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2021 and has held it in 9 quarters since.
David Einhorn's Lakefront Biotherapeutics American Depositary Shares position peaked at $10.2M in Q4 2021.
88 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2023.

Based on Greenlight Capital's 13F filing for Q4 2023, filed 14 Feb 2024.